Seoul National University Hospital

Seoul, Jongno-gu 110-744

4 studies enrolling now · 17 studies all time

What they study most

ALK-positive Non-small Cell Lung Cancer (NSCLC), Acral Melanoma, Acute Myeloid Leukemia, Advanced Solid Tumor, Advanced Solid Tumors With KRAS G12C Mutations, Atrial Fibrillation, Basal Cell Carcinoma, Bladder Cancer, COVID-19, Cancer With A High Tumor Mutational Burden, Cardiovascular Diseases, Cervical Cancer

Studies at this site

• A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors — Recruiting now
• A Beta-only IL-2 ImmunoTherapY Study — Recruiting now
• Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors — Available (expanded access)
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease — Starting soon
• Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients — Stopped early
• Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) — Completed
• PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL — Completed
• ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 — Completed
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis — Stopped early
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) — Completed
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• Adaptive COVID-19 Treatment Trial (ACTT) — Completed
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) — Completed
• Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor — Completed
• Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma — Stopped early